In sports, doping refers to “the use of performance-enhancing drugs”, emphasis on performance-enhancing. The very basis of the definition lies in the fact, that to measure an ‘enhancement’ there has to be some sort of an established baseline, that is, a base performance level at which the athlete would normally compete. It is therefore crucial to determine the standards for that baseline, be it 45±7 PCV for hematocrit levels, 0-20 mU/ml for EPO levels, or XYZ for testosterone levels in this case.

Now, it seems only natural to postulate that there be differences in these baseline levels based on age, gender, muscle mass, and (yes, we have to go there) race. What FIFA’s study is simply trying to establish here, is that there be no unfair advantage created by (in this case) the race difference, such that a white athlete (to give you an example) may be given a free pass on an urine test while a black athlete will not, simply because the black athlete has already naturally high levels of the substance being tested for.

Now while I agree with you that the issue is controversial, there is nothing racist in making these determinations. As you yourself pointed out, FIFA are acting with the best intentions, and it would be a grave mistake to dismiss age, gender, and race differences just because of an ethical standard which in this case is not even under attack.